Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer's Setbacks With Paxlovid Are Mounting -- Should Investors Be Concerned?
Pfizer's Setbacks With Paxlovid Are Mounting -- Should Investors Be Concerned?
Pfizer's Setbacks With Paxlovid Are Mounting -- Should Investors Be Concerned?
Submitted by
admin
on May 18, 2022 - 10:26am
Source:
Motley Fool
News Tags:
Pfizer
COVID-19
Paxlovid
Headline:
Pfizer's Setbacks With Paxlovid Are Mounting -- Should Investors Be Concerned?
snippet:
Paxlovid sales weren't as high as expected.
The drug's total addressable market may not be as large as investors initially hoped.
Emerging concerns about rebounding COVID-19 symptoms after treatment are not reassuring.
Do Not Allow Advertisers to Use My Personal information